Department of Surgery, Chonnam National University Hwasun Hospital and Medical School, Gwangju, Korea.
J Gastrointest Surg. 2010 Jul;14(7):1074-80. doi: 10.1007/s11605-010-1206-y. Epub 2010 Apr 30.
The aim of the study was to evaluate factors for predicting lymph node metastasis in patients who had T1 and T2 colorectal cancer.
A total of 224 patients with T1 or T2 colorectal cancers who underwent radical surgery with regional lymphadenectomy from January 1999 to January 2008 were analyzed.
Predictive factors for lymph node metastasis and prognostic factors were analyzed. Tumor stage was classified as T1 in 69 (30.8%) and T2 in 155 (69.2%) of patients. The overall incidence of lymph node metastasis was 21.0% (14.5% for T1 cancer and 23.9% for T2 cancer; P = 0.112). The node positive and negative groups were similar with regard to patient demographics, except that the former contained a significantly higher number of lymphovascular invasion and perineural invasion cases. During the median follow-up period of 49 months, the 5-year overall and disease-free survival rates for patients without lymph node metastasis were 97.1% and 94.6%, which were significantly higher than the rates for those with lymph node metastasis (85.5%, P = 0.008, and 82.0%, P = 0.007, respectively). A multivariate analysis revealed that lymph node status was the only significant independent prognostic factor for both overall survival (P = 0.025) and disease-free survival (P = 0.040). Moreover, the presence of lymphovascular invasion (P < 0.001) or perineural invasion (P = 0.004) was an independent predictor for lymph node metastasis.
Lymph node metastasis was the most powerful predictor for poorer survival in patients with T1 or T2 colorectal cancer. For patients with positive lymphovascular or perineural invasion, radical surgery should be recommended because of a greater chance for lymph node metastasis.
本研究旨在评估 T1 和 T2 结直肠癌患者发生淋巴结转移的预测因素。
回顾性分析 1999 年 1 月至 2008 年 1 月行根治性手术加区域淋巴结清扫术的 224 例 T1 或 T2 结直肠癌患者的临床资料。
分析了淋巴结转移的预测因素和预后因素。肿瘤分期:T1 期 69 例(30.8%),T2 期 155 例(69.2%)。淋巴结转移的总发生率为 21.0%(T1 癌为 14.5%,T2 癌为 23.9%;P = 0.112)。阳性组和阴性组在患者人口统计学方面无显著差异,阳性组中血管淋巴管浸润和神经周围浸润的比例显著高于阴性组。在中位随访 49 个月期间,无淋巴结转移患者的 5 年总生存率和无病生存率分别为 97.1%和 94.6%,显著高于淋巴结转移患者(85.5%,P = 0.008;82.0%,P = 0.007)。多因素分析显示,淋巴结状态是总生存(P = 0.025)和无病生存(P = 0.040)的唯一独立预后因素。此外,存在血管淋巴管浸润(P < 0.001)或神经周围浸润(P = 0.004)是淋巴结转移的独立预测因素。
淋巴结转移是 T1 或 T2 结直肠癌患者生存较差的最强预测因素。对于有血管淋巴管浸润或神经周围浸润的患者,应推荐行根治性手术,因为淋巴结转移的可能性更大。